Skip to main content
. Author manuscript; available in PMC: 2010 Feb 18.
Published in final edited form as: Cancer Res. 2008 Jul 15;68(14):5619–5627. doi: 10.1158/0008-5472.CAN-08-1274

Figure 2. Uteri from Ptenpr−/− and Ptenpr−/−/p53pr−/− show aberrant histology and their loss affects survival.

Figure 2

Histology of A) Ptenpr/ and B) Ptenpr//p53pr/ uteri. Hematoxylin and Eosin (H & E) and cytokeratin 8 (CK8) staining of A) Ptenpr/ and B) Ptenpr//p53pr/ uteri in mice at various ages (10 days, 3 weeks, 1 month, 2 months and 3 months). C) Effects of endometrial loss of Pten and/or p53 on survival. Wild-type, Ptenpr/, p53pr/ and Ptenpr//p53pr/ mice were monitored for any sign of sickness for a total of 250 days. We sacrificed mice with any sign of sickness or discomfort and the day of sacrifice was recorded.

HHS Vulnerability Disclosure